Gedeon Richter, Actavis report positive top line results from cariprazine Phase III trial
Gedeon Richter Plc. and Actavis plc today announced positive results from a Phase III trial evaluating the efficacy and safety of cariprazine in the prevention of relapse in patients with schizophrenia...